Qualitek Labs Limited has announced a Live Investor Relations (IR) Interaction scheduled for February 21, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed the Bombay Stock Exchange on February 17, 2026, about this upcoming virtual engagement with investors.

Event Details

The investor relations interaction will be conducted in a virtual format, providing accessibility to a broader investor base. The event is structured as a general interaction session rather than a formal analyst or earnings call.

Key Participants

The interaction will feature two primary participants who will engage with the investor community. Mr. Antaryami Nayak, Managing Director of Qualitek Labs Limited, will represent the company's leadership perspective. Dr. Nikesh Yadav from Investor and Microcap Research will also participate in the session.

Interaction Scope and Compliance

The company has clearly outlined that the interaction is intended to facilitate general discussions with investors regarding the business overview and growth outlook. Qualitek Labs Limited has emphasized that this session does not constitute an analyst or earnings call, maintaining transparency about the nature of the engagement.

In adherence to regulatory requirements, the company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the course of the interaction. This commitment ensures compliance with SEBI guidelines and maintains fair disclosure practices.

Regulatory Compliance

The announcement fulfills the disclosure requirements under Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015. As an entity listed on the BSE SME Platform with scrip code 544091, Qualitek Labs Limited has provided the necessary intimation to the exchange within the prescribed regulatory framework.

Additional information about the interaction is available on the company's website at www.qualiteklab.com/compliances/ , providing investors with easy access to relevant details and ensuring transparent communication.

Qualitek Labs Limited has provided detailed clarification to the Bombay Stock Exchange regarding the resignation of its Company Secretary and Compliance Officer, following observations raised by the exchange on regulatory compliance requirements.

Resignation Timeline and Details

The clarification addresses the resignation of Mr. Mayank Garg (ACS: 76038), who served as Company Secretary and Compliance Officer. The resignation process unfolded over several months, with specific dates highlighting the timeline of events.

Regulatory Compliance Clarification

The company's clarification was submitted in response to BSE observations regarding additional details required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The exchange had raised observations following the corporate announcement made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company explained that the effective cessation date of February 07, 2026, fell on a Saturday, which was a non-working day. Consequently, the mandatory disclosure under Regulation 30 was made on the next working day, February 09, 2026, after completing internal procedural formalities.

Employment Details and Background

According to the relieving certificate, Mayank Garg was employed with Qualitek Labs Limited from April 07, 2025, to February 07, 2026, serving in the Legal Department as Company Secretary. The employment duration was approximately 10 months.

Reason for Resignation

The company disclosed that Garg's resignation was submitted to pursue alternate professional opportunities outside the organization. The resignation letter indicated his intention to resign from all statutory and designated positions held within the company. The company confirmed there are no material reasons for the resignation beyond those stated.

Additionally, the company clarified that Mayank Garg does not hold any shares in the company and is not related to any Director of the company, addressing potential conflict of interest considerations.

Documentation and Compliance

The clarification was signed by Managing Director Antaryami Nayak (DIN: 07232463) and included supporting documentation such as the acceptance letter and relieving letter as annexures. The relieving certificate was authorized by Ashok Kumar Agrawal, AVP of HR & Admin Department.

The company requested the exchange to take the clarification and additional details on record, demonstrating its commitment to regulatory compliance and transparent disclosure practices under the SEBI LODR Regulations.